Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 22, 2024Nature MicrobiologyOpen Access

Fc-engineered antibodies promote neutrophil-dependent control of Mycobacterium tuberculosis

View Full Paper
Ask AI
Bookmark
Share

Authors

EIEdward B. IrvineANAngel NikolovMKMehak Zahoor Khan

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Irvine et al. (2024) studied this question.

synapsesocial.com/papers/68e5b4dfb6db64358754d685https://doi.org/10.1038/s41564-024-01777-9
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis2020 · 245 citations
  2. 2Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease2006 · 313 citations
  3. 3Engineered Antibodies with Increased Activity to Recruit Complement2001 · 293 citations
  4. 4Increasing the Affinity of a Human IgG1 for the Neonatal Fc Receptor: Biological Consequences2002 · 364 citations
  5. 5Neutrophils in tuberculosis – first line of defence or booster of disease and targets for host directed therapy?2016 · 96 citations